P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY. (23rd June 2022) - Dimou, M.; Speletas, M.; Milito, C.; Huscher, D.; Kamieniak, M.; Pittrow, D.; Borte, M.